All News #Library
Biotech
Skyhawk, Santhera Name New CCO`s To Steer Commercial Paths
11 Mar 2026 //
FIERCE PHARMA
Skyhawk Pharma Names Aaron Deves Chief Commercial Officer
10 Mar 2026 //
PR NEWSWIRE BIO
Skyhawk Therapeutics Reveals Phase 1 Trial Progress For SKY-0515
27 Jan 2026 //
PR NEWSWIRE
Skyhawk Therapeutics Reports Positive Phase 1 Results
17 Sep 2025 //
PR NEWSWIRE
Merck KGaA Partner with Skyhawk in $2B RNA Splicing Collaboration
19 Aug 2025 //
PRESS RELEASE
Skyhawk Receives Australian Approval to SKY-0515 in Huntington
09 Dec 2024 //
PR NEWSWIRE
Skyhawk Presents SKY-1214 Data At EORTC-NCI-AACR Symposium
24 Oct 2024 //
PR NEWSWIRE
Skyhawk To Present SKY-0515 Phase 1 Data At Huntington`s Disease Network
11 Sep 2024 //
PR NEWSWIRE
Skyhawk Reports Positive Phase 1 Results For SKY-0515 In Huntington`s
10 Jul 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support